 Solana Beach, California--Newsfile Corp. - April 26, 2022 - Artelo Biosciences, Inc. NASDAQ: ARTL, a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory Gorgas, Chief Executive Officer of Artelo, will present at The Q2 Investor Summit, hosted by the Investor Summit Group, being held on May 3-4, 2022 at The Westin New York Grand Central.Event: The Q2 Investor Summit GroupDate: ... 